S-8:員工福利計劃證券登記
8-K:重大事件
10-Q:季度報表
8-K:Reviva公佈2024年第一季度財務業績和近期業務亮點
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 10-K:年度報表
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | NT 10-K:其他
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13D/A:超過5%持股股東披露文件(修正)-Laxminarayan Bhat(10.2%)
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13G/A:超過5%持股股東披露文件(修正)-TANG CAPITAL PARTNERS, LP(9.99%),TANG CAPITAL MANAGEMENT, LLC(9.99%)等
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13G:超過5%持股股東披露文件-Armistice Capital, LLC(6.32%),Steven Boyd(6.32%)
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | EFFECT:其他
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 424B4:募資說明書
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | CORRESP:信函
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | UPLOAD:其他
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | S-3:特定交易註冊聲明
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | SC 13D/A:超過5%持股股東披露文件(修正)-Parag Saxena(19.9%),Vedanta Partners, LLC(19.4%)等
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 4:持股變動聲明-董事 SAXENA PARAG
REVIVA PHARMACEUTICALS HOLDINGS INC C/WTS 25/12/2025(TO PUR COM) | 8-K:重大事件
暫無數據